I. Meeting Information
The notice for the 14th meeting of the 2nd Board of Directors of Yili Chuaning Biotechnology Co., Ltd. (hereinafter referred to as "the Company") was delivered on March 17, 2026, via personal delivery, email, and phone notification. The meeting was held on March 27, 2026, at 11:00 AM, combining on-site and communication voting methods. A total of 7 directors were supposed to attend, and all 7 directors were present. The meeting was chaired by Mr. Liu Gexin, and all senior management attended the meeting. The convening and holding of this meeting complied with the relevant provisions of the Company Law of the People's Republic of China and other relevant laws, regulations, departmental rules, normative documents, and the Company's Articles of Association, making the resolutions legally valid.
II. Meeting Resolutions
After careful consideration by the attending directors, the following resolutions were passed by written ballot:
(1) Approval of the 2025 Annual Work Report of the Board of Directors
With 7 votes in favor, 0 votes against, and 0 abstentions, the proposal regarding the 2025 Annual Work Report of the Board of Directors was approved. The independent directors submitted their annual work reports, which will be presented at the 2025 annual shareholders' meeting. The board evaluated the independence of the independent directors based on their self-assessment report and issued a special evaluation opinion. Specific details can be found in the disclosures on March 31, 2026, in the Securities Times, Shanghai Securities Journal, China Securities Journal, and the designated information disclosure website, www.cninfo.com.cn.
(2) Approval of the 2025 Annual General Manager Work Report
With 7 votes in favor, 0 votes against, and 0 abstentions, the proposal regarding the 2025 Annual General Manager Work Report was approved. The general manager submitted the report based on the execution of board resolutions and daily management operations.